Combination of Carbon Dioxide (CO2) Laser and Triamcinolone Acetonide for Keloid and Hypertrophic Scar Treatment: A Systematic Review [0.03%]
二氧化碳激光联合曲安奈德治疗瘢痕增生的系统评价
Miranda K Branyiczky,Dea Metko,Jeffrey T S Hsu et al.
Miranda K Branyiczky et al.
Friend or Foe: A Systematic Review of Dupilumab and Alopecia Areata [0.03%]
朋友还是敌人：Dupixent治疗斑秃的系统性综述
Anagha Srivatsa,Madison G Romanski,Wasey Rehman et al.
Anagha Srivatsa et al.
Fournier's Gangrene After Starting Glucose Lowering Medications: A retrospective cohort study [0.03%]
降糖药物起始治疗后的福恩戈尔氏坏疽：一项队列研究
Michael S Kolodney,Iraj Hasan,Olivia Lim
Michael S Kolodney
High magnification Smartphone-Dermatoscope Integration: A Portable and Accessible Alternative to Super High-Magnification Videodermatoscopy [0.03%]
高放大倍率的智能手机-皮肤镜集成：超高清视频皮肤镜检查的便携且易用的替代方法
Paweł Pietkiewicz,Piotr Szlązak,Anna Słomiak-Wąsik et al.
Paweł Pietkiewicz et al.
Personalized UVA1 Phototherapy Strategies for Steroid-Refractory Hand-Foot Eczema: A Prospective Study [0.03%]
一项前瞻性研究：针对糖皮质激素难治性手足湿疹的个性化UVA1光疗策略
Yu Hu,Liangliang Zhang,Hongying Chen et al.
Yu Hu et al.
Alternating single section specimen for large tumors removed by Mohs micrographic surgery [0.03%]
莫式手术切除巨大肿物时的单份标本周期交替法
F B Cerci,B C M Chaves,S N Tolkachjov
F B Cerci
Utilization and outcomes of Mohs micrographic surgery versus wide local excision in sebaceous carcinoma: a retrospective cohort analysis [0.03%]
Mohs显微手术与广泛局部切除治疗皮脂腺癌的利用情况和预后效果：回顾性队列研究
Maggie H Zhou,Vijay Kodumudi,Nima Gharavi et al.
Maggie H Zhou et al.
Advancements in Diversity in Dermatology: A 5-Year Retrospective Analysis of Racial and Ethnic Trends in U.S. Dermatology Residency Programs (2020-2024) [0.03%]
美国皮肤病学住院医师项目中(2020-2024年)种族和族裔趋势的五年回顾分析——皮肤病学多样性的进步
Devin Barzallo,Afua Ofori-Darko,Larissa De Souza et al.
Devin Barzallo et al.
Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind Study [0.03%]
芦可替尼乳膏治疗2至11岁特应性皮炎患儿的疗效和安全性：TRuE-AD3三期随机双盲研究结果
Lawrence F Eichenfield,Linda F Stein Gold,Eric L Simpson et al.
Lawrence F Eichenfield et al.
Efficacy, safety, and B-cell depletion capacity of three rituximab dosing regimens in the treatment of moderate-to-severe pemphigus vulgaris and pemphigus foliaceus: a 52-week clinical trial [0.03%]
不同剂量利妥昔单抗治疗中重度寻常型天疱疮和落叶性天疱疮疗效、安全性和B细胞耗竭能力的随机对照研究：为期52周的临床试验
Shan Cao,Baoqi Yang,Zhenzhen Wang et al.
Shan Cao et al.
Background: Rituximab (RTX) is effective for pemphigus, but optimal dosing remains uncertain. Objective: Compare efficacy, safety, and ...